Global GLP-1 Agonist Injection Supply, Demand and Key Producers, 2024-2030
Page: 102
Published Date: 28 Mar 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
GLP-1 (glucagon-like peptide-1) agonists are a class of medications that mainly help manage blood sugar (glucose) levels in people with Type 2 diabetes. Some GLP-1 agonists can also help treat obesity. GLP-1 agonist medicines include injections and oral medications.
The global GLP-1 Agonist Injection market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).
This report studies the global GLP-1 Agonist Injection production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for GLP-1 Agonist Injection and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of GLP-1 Agonist Injection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global GLP-1 Agonist Injection total production and demand, 2019-2030, (K Dose)
Global GLP-1 Agonist Injection total production value, 2019-2030, (USD Million)
Global GLP-1 Agonist Injection production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Dose), (based on production site)
Global GLP-1 Agonist Injection consumption by region & country, CAGR, 2019-2030 & (K Dose)
U.S. VS China: GLP-1 Agonist Injection domestic production, consumption, key domestic manufacturers and share
Global GLP-1 Agonist Injection production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Dose)
Global GLP-1 Agonist Injection production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Dose)
Global GLP-1 Agonist Injection production by Application, production, value, CAGR, 2019-2030, (USD Million) & (K Dose)
This report profiles key players in the global GLP-1 Agonist Injection market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Eli Lilly, AstraZeneca, GSK, Sanofi, Amylin, Huadong Medicine, Shanghai Benemae Pharmaceutical Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World GLP-1 Agonist Injection market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Dose) and average price (US$/Dose) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global GLP-1 Agonist Injection Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global GLP-1 Agonist Injection Market, Segmentation by Type:
Short-acting Preparations
Long-acting Preparations
Global GLP-1 Agonist Injection Market, Segmentation by Application:
Diabetes
Obesity
Companies Profiled:
Novo Nordisk
Eli Lilly
AstraZeneca
GSK
Sanofi
Amylin
Huadong Medicine
Shanghai Benemae Pharmaceutical Corporation
Key Questions Answered:
1. How big is the global GLP-1 Agonist Injection market?
2. What is the demand of the global GLP-1 Agonist Injection market?
3. What is the year over year growth of the global GLP-1 Agonist Injection market?
4. What is the production and production value of the global GLP-1 Agonist Injection market?
5. Who are the key producers in the global GLP-1 Agonist Injection market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 GLP-1 Agonist Injection Introduction
1.2 World GLP-1 Agonist Injection Supply & Forecast
1.2.1 World GLP-1 Agonist Injection Production Value (2019 & 2023 & 2030)
1.2.2 World GLP-1 Agonist Injection Production (2019-2030)
1.2.3 World GLP-1 Agonist Injection Pricing Trends (2019-2030)
1.3 World GLP-1 Agonist Injection Production by Region (Based on Production Site)
1.3.1 World GLP-1 Agonist Injection Production Value by Region (2019-2030)
1.3.2 World GLP-1 Agonist Injection Production by Region (2019-2030)
1.3.3 World GLP-1 Agonist Injection Average Price by Region (2019-2030)
1.3.4 North America GLP-1 Agonist Injection Production (2019-2030)
1.3.5 Europe GLP-1 Agonist Injection Production (2019-2030)
1.3.6 China GLP-1 Agonist Injection Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 GLP-1 Agonist Injection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 GLP-1 Agonist Injection Major Market Trends
2.1 World GLP-1 Agonist Injection Demand (2019-2030)
2.2 World GLP-1 Agonist Injection Consumption by Region
2.2.1 World GLP-1 Agonist Injection Consumption by Region (2019-2024)
2.2.2 World GLP-1 Agonist Injection Consumption Forecast by Region (2025-2030)
2.3 United States GLP-1 Agonist Injection Consumption (2019-2030)
2.4 China GLP-1 Agonist Injection Consumption (2019-2030)
2.5 Europe GLP-1 Agonist Injection Consumption (2019-2030)
2.6 Japan GLP-1 Agonist Injection Consumption (2019-2030)
2.7 South Korea GLP-1 Agonist Injection Consumption (2019-2030)
2.8 ASEAN GLP-1 Agonist Injection Consumption (2019-2030)
2.9 India GLP-1 Agonist Injection Consumption (2019-2030)
3.1 World GLP-1 Agonist Injection Production Value by Manufacturer (2019-2024)
3.2 World GLP-1 Agonist Injection Production by Manufacturer (2019-2024)
3.3 World GLP-1 Agonist Injection Average Price by Manufacturer (2019-2024)
3.4 GLP-1 Agonist Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global GLP-1 Agonist Injection Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for GLP-1 Agonist Injection in 2023
3.5.3 Global Concentration Ratios (CR8) for GLP-1 Agonist Injection in 2023
3.6 GLP-1 Agonist Injection Market: Overall Company Footprint Analysis
3.6.1 GLP-1 Agonist Injection Market: Region Footprint
3.6.2 GLP-1 Agonist Injection Market: Company Product Type Footprint
3.6.3 GLP-1 Agonist Injection Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: GLP-1 Agonist Injection Production Value Comparison
4.1.1 United States VS China: GLP-1 Agonist Injection Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: GLP-1 Agonist Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: GLP-1 Agonist Injection Production Comparison
4.2.1 United States VS China: GLP-1 Agonist Injection Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: GLP-1 Agonist Injection Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: GLP-1 Agonist Injection Consumption Comparison
4.3.1 United States VS China: GLP-1 Agonist Injection Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: GLP-1 Agonist Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based GLP-1 Agonist Injection Manufacturers and Market Share, 2019-2024
4.4.1 United States Based GLP-1 Agonist Injection Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers GLP-1 Agonist Injection Production Value (2019-2024)
4.4.3 United States Based Manufacturers GLP-1 Agonist Injection Production (2019-2024)
4.5 China Based GLP-1 Agonist Injection Manufacturers and Market Share
4.5.1 China Based GLP-1 Agonist Injection Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers GLP-1 Agonist Injection Production Value (2019-2024)
4.5.3 China Based Manufacturers GLP-1 Agonist Injection Production (2019-2024)
4.6 Rest of World Based GLP-1 Agonist Injection Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based GLP-1 Agonist Injection Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers GLP-1 Agonist Injection Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers GLP-1 Agonist Injection Production (2019-2024)
5.1 World GLP-1 Agonist Injection Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Short-acting Preparations
5.2.2 Long-acting Preparations
5.3 Market Segment by Type
5.3.1 World GLP-1 Agonist Injection Production by Type (2019-2030)
5.3.2 World GLP-1 Agonist Injection Production Value by Type (2019-2030)
5.3.3 World GLP-1 Agonist Injection Average Price by Type (2019-2030)
6.1 World GLP-1 Agonist Injection Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Diabetes
6.2.2 Obesity
6.3 Market Segment by Application
6.3.1 World GLP-1 Agonist Injection Production by Application (2019-2030)
6.3.2 World GLP-1 Agonist Injection Production Value by Application (2019-2030)
6.3.3 World GLP-1 Agonist Injection Average Price by Application (2019-2030)
7.1 Novo Nordisk
7.1.1 Novo Nordisk Details
7.1.2 Novo Nordisk Major Business
7.1.3 Novo Nordisk GLP-1 Agonist Injection Product and Services
7.1.4 Novo Nordisk GLP-1 Agonist Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Novo Nordisk Recent Developments/Updates
7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
7.2 Eli Lilly
7.2.1 Eli Lilly Details
7.2.2 Eli Lilly Major Business
7.2.3 Eli Lilly GLP-1 Agonist Injection Product and Services
7.2.4 Eli Lilly GLP-1 Agonist Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Eli Lilly Recent Developments/Updates
7.2.6 Eli Lilly Competitive Strengths & Weaknesses
7.3 AstraZeneca
7.3.1 AstraZeneca Details
7.3.2 AstraZeneca Major Business
7.3.3 AstraZeneca GLP-1 Agonist Injection Product and Services
7.3.4 AstraZeneca GLP-1 Agonist Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 AstraZeneca Recent Developments/Updates
7.3.6 AstraZeneca Competitive Strengths & Weaknesses
7.4 GSK
7.4.1 GSK Details
7.4.2 GSK Major Business
7.4.3 GSK GLP-1 Agonist Injection Product and Services
7.4.4 GSK GLP-1 Agonist Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 GSK Recent Developments/Updates
7.4.6 GSK Competitive Strengths & Weaknesses
7.5 Sanofi
7.5.1 Sanofi Details
7.5.2 Sanofi Major Business
7.5.3 Sanofi GLP-1 Agonist Injection Product and Services
7.5.4 Sanofi GLP-1 Agonist Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Sanofi Recent Developments/Updates
7.5.6 Sanofi Competitive Strengths & Weaknesses
7.6 Amylin
7.6.1 Amylin Details
7.6.2 Amylin Major Business
7.6.3 Amylin GLP-1 Agonist Injection Product and Services
7.6.4 Amylin GLP-1 Agonist Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Amylin Recent Developments/Updates
7.6.6 Amylin Competitive Strengths & Weaknesses
7.7 Huadong Medicine
7.7.1 Huadong Medicine Details
7.7.2 Huadong Medicine Major Business
7.7.3 Huadong Medicine GLP-1 Agonist Injection Product and Services
7.7.4 Huadong Medicine GLP-1 Agonist Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Huadong Medicine Recent Developments/Updates
7.7.6 Huadong Medicine Competitive Strengths & Weaknesses
7.8 Shanghai Benemae Pharmaceutical Corporation
7.8.1 Shanghai Benemae Pharmaceutical Corporation Details
7.8.2 Shanghai Benemae Pharmaceutical Corporation Major Business
7.8.3 Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Product and Services
7.8.4 Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Shanghai Benemae Pharmaceutical Corporation Recent Developments/Updates
7.8.6 Shanghai Benemae Pharmaceutical Corporation Competitive Strengths & Weaknesses
8.1 GLP-1 Agonist Injection Industry Chain
8.2 GLP-1 Agonist Injection Upstream Analysis
8.2.1 GLP-1 Agonist Injection Core Raw Materials
8.2.2 Main Manufacturers of GLP-1 Agonist Injection Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 GLP-1 Agonist Injection Production Mode
8.6 GLP-1 Agonist Injection Procurement Model
8.7 GLP-1 Agonist Injection Industry Sales Model and Sales Channels
8.7.1 GLP-1 Agonist Injection Sales Model
8.7.2 GLP-1 Agonist Injection Typical Distributors
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World GLP-1 Agonist Injection Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World GLP-1 Agonist Injection Production Value by Region (2019-2024) & (USD Million)
Table 3. World GLP-1 Agonist Injection Production Value by Region (2025-2030) & (USD Million)
Table 4. World GLP-1 Agonist Injection Production Value Market Share by Region (2019-2024)
Table 5. World GLP-1 Agonist Injection Production Value Market Share by Region (2025-2030)
Table 6. World GLP-1 Agonist Injection Production by Region (2019-2024) & (K Dose)
Table 7. World GLP-1 Agonist Injection Production by Region (2025-2030) & (K Dose)
Table 8. World GLP-1 Agonist Injection Production Market Share by Region (2019-2024)
Table 9. World GLP-1 Agonist Injection Production Market Share by Region (2025-2030)
Table 10. World GLP-1 Agonist Injection Average Price by Region (2019-2024) & (US$/Dose)
Table 11. World GLP-1 Agonist Injection Average Price by Region (2025-2030) & (US$/Dose)
Table 12. GLP-1 Agonist Injection Major Market Trends
Table 13. World GLP-1 Agonist Injection Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Dose)
Table 14. World GLP-1 Agonist Injection Consumption by Region (2019-2024) & (K Dose)
Table 15. World GLP-1 Agonist Injection Consumption Forecast by Region (2025-2030) & (K Dose)
Table 16. World GLP-1 Agonist Injection Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key GLP-1 Agonist Injection Producers in 2023
Table 18. World GLP-1 Agonist Injection Production by Manufacturer (2019-2024) & (K Dose)
Table 19. Production Market Share of Key GLP-1 Agonist Injection Producers in 2023
Table 20. World GLP-1 Agonist Injection Average Price by Manufacturer (2019-2024) & (US$/Dose)
Table 21. Global GLP-1 Agonist Injection Company Evaluation Quadrant
Table 22. World GLP-1 Agonist Injection Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and GLP-1 Agonist Injection Production Site of Key Manufacturer
Table 24. GLP-1 Agonist Injection Market: Company Product Type Footprint
Table 25. GLP-1 Agonist Injection Market: Company Product Application Footprint
Table 26. GLP-1 Agonist Injection Competitive Factors
Table 27. GLP-1 Agonist Injection New Entrant and Capacity Expansion Plans
Table 28. GLP-1 Agonist Injection Mergers & Acquisitions Activity
Table 29. United States VS China GLP-1 Agonist Injection Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China GLP-1 Agonist Injection Production Comparison, (2019 & 2023 & 2030) & (K Dose)
Table 31. United States VS China GLP-1 Agonist Injection Consumption Comparison, (2019 & 2023 & 2030) & (K Dose)
Table 32. United States Based GLP-1 Agonist Injection Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers GLP-1 Agonist Injection Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers GLP-1 Agonist Injection Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers GLP-1 Agonist Injection Production (2019-2024) & (K Dose)
Table 36. United States Based Manufacturers GLP-1 Agonist Injection Production Market Share (2019-2024)
Table 37. China Based GLP-1 Agonist Injection Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers GLP-1 Agonist Injection Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers GLP-1 Agonist Injection Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers GLP-1 Agonist Injection Production, (2019-2024) & (K Dose)
Table 41. China Based Manufacturers GLP-1 Agonist Injection Production Market Share (2019-2024)
Table 42. Rest of World Based GLP-1 Agonist Injection Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers GLP-1 Agonist Injection Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers GLP-1 Agonist Injection Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers GLP-1 Agonist Injection Production, (2019-2024) & (K Dose)
Table 46. Rest of World Based Manufacturers GLP-1 Agonist Injection Production Market Share (2019-2024)
Table 47. World GLP-1 Agonist Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World GLP-1 Agonist Injection Production by Type (2019-2024) & (K Dose)
Table 49. World GLP-1 Agonist Injection Production by Type (2025-2030) & (K Dose)
Table 50. World GLP-1 Agonist Injection Production Value by Type (2019-2024) & (USD Million)
Table 51. World GLP-1 Agonist Injection Production Value by Type (2025-2030) & (USD Million)
Table 52. World GLP-1 Agonist Injection Average Price by Type (2019-2024) & (US$/Dose)
Table 53. World GLP-1 Agonist Injection Average Price by Type (2025-2030) & (US$/Dose)
Table 54. World GLP-1 Agonist Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World GLP-1 Agonist Injection Production by Application (2019-2024) & (K Dose)
Table 56. World GLP-1 Agonist Injection Production by Application (2025-2030) & (K Dose)
Table 57. World GLP-1 Agonist Injection Production Value by Application (2019-2024) & (USD Million)
Table 58. World GLP-1 Agonist Injection Production Value by Application (2025-2030) & (USD Million)
Table 59. World GLP-1 Agonist Injection Average Price by Application (2019-2024) & (US$/Dose)
Table 60. World GLP-1 Agonist Injection Average Price by Application (2025-2030) & (US$/Dose)
Table 61. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 62. Novo Nordisk Major Business
Table 63. Novo Nordisk GLP-1 Agonist Injection Product and Services
Table 64. Novo Nordisk GLP-1 Agonist Injection Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Novo Nordisk Recent Developments/Updates
Table 66. Novo Nordisk Competitive Strengths & Weaknesses
Table 67. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 68. Eli Lilly Major Business
Table 69. Eli Lilly GLP-1 Agonist Injection Product and Services
Table 70. Eli Lilly GLP-1 Agonist Injection Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Eli Lilly Recent Developments/Updates
Table 72. Eli Lilly Competitive Strengths & Weaknesses
Table 73. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Major Business
Table 75. AstraZeneca GLP-1 Agonist Injection Product and Services
Table 76. AstraZeneca GLP-1 Agonist Injection Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. AstraZeneca Recent Developments/Updates
Table 78. AstraZeneca Competitive Strengths & Weaknesses
Table 79. GSK Basic Information, Manufacturing Base and Competitors
Table 80. GSK Major Business
Table 81. GSK GLP-1 Agonist Injection Product and Services
Table 82. GSK GLP-1 Agonist Injection Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. GSK Recent Developments/Updates
Table 84. GSK Competitive Strengths & Weaknesses
Table 85. Sanofi Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Major Business
Table 87. Sanofi GLP-1 Agonist Injection Product and Services
Table 88. Sanofi GLP-1 Agonist Injection Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Sanofi Recent Developments/Updates
Table 90. Sanofi Competitive Strengths & Weaknesses
Table 91. Amylin Basic Information, Manufacturing Base and Competitors
Table 92. Amylin Major Business
Table 93. Amylin GLP-1 Agonist Injection Product and Services
Table 94. Amylin GLP-1 Agonist Injection Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Amylin Recent Developments/Updates
Table 96. Amylin Competitive Strengths & Weaknesses
Table 97. Huadong Medicine Basic Information, Manufacturing Base and Competitors
Table 98. Huadong Medicine Major Business
Table 99. Huadong Medicine GLP-1 Agonist Injection Product and Services
Table 100. Huadong Medicine GLP-1 Agonist Injection Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Huadong Medicine Recent Developments/Updates
Table 102. Huadong Medicine Competitive Strengths & Weaknesses
Table 103. Shanghai Benemae Pharmaceutical Corporation Basic Information, Manufacturing Base and Competitors
Table 104. Shanghai Benemae Pharmaceutical Corporation Major Business
Table 105. Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Product and Services
Table 106. Shanghai Benemae Pharmaceutical Corporation GLP-1 Agonist Injection Production (K Dose), Price (US$/Dose), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Shanghai Benemae Pharmaceutical Corporation Recent Developments/Updates
Table 108. Shanghai Benemae Pharmaceutical Corporation Competitive Strengths & Weaknesses
Table 109. Global Key Players of GLP-1 Agonist Injection Upstream (Raw Materials)
Table 110. Global GLP-1 Agonist Injection Typical Customers
Table 111. GLP-1 Agonist Injection Typical Distributors
List of Figures
Figure 1. GLP-1 Agonist Injection Picture
Figure 2. World GLP-1 Agonist Injection Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World GLP-1 Agonist Injection Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World GLP-1 Agonist Injection Production (2019-2030) & (K Dose)
Figure 5. World GLP-1 Agonist Injection Average Price (2019-2030) & (US$/Dose)
Figure 6. World GLP-1 Agonist Injection Production Value Market Share by Region (2019-2030)
Figure 7. World GLP-1 Agonist Injection Production Market Share by Region (2019-2030)
Figure 8. North America GLP-1 Agonist Injection Production (2019-2030) & (K Dose)
Figure 9. Europe GLP-1 Agonist Injection Production (2019-2030) & (K Dose)
Figure 10. China GLP-1 Agonist Injection Production (2019-2030) & (K Dose)
Figure 11. GLP-1 Agonist Injection Market Drivers
Figure 12. Factors Affecting Demand
Figure 13. World GLP-1 Agonist Injection Consumption (2019-2030) & (K Dose)
Figure 14. World GLP-1 Agonist Injection Consumption Market Share by Region (2019-2030)
Figure 15. United States GLP-1 Agonist Injection Consumption (2019-2030) & (K Dose)
Figure 16. China GLP-1 Agonist Injection Consumption (2019-2030) & (K Dose)
Figure 17. Europe GLP-1 Agonist Injection Consumption (2019-2030) & (K Dose)
Figure 18. Japan GLP-1 Agonist Injection Consumption (2019-2030) & (K Dose)
Figure 19. South Korea GLP-1 Agonist Injection Consumption (2019-2030) & (K Dose)
Figure 20. ASEAN GLP-1 Agonist Injection Consumption (2019-2030) & (K Dose)
Figure 21. India GLP-1 Agonist Injection Consumption (2019-2030) & (K Dose)
Figure 22. Producer Shipments of GLP-1 Agonist Injection by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 23. Global Four-firm Concentration Ratios (CR4) for GLP-1 Agonist Injection Markets in 2023
Figure 24. Global Four-firm Concentration Ratios (CR8) for GLP-1 Agonist Injection Markets in 2023
Figure 25. United States VS China: GLP-1 Agonist Injection Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 26. United States VS China: GLP-1 Agonist Injection Production Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: GLP-1 Agonist Injection Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States Based Manufacturers GLP-1 Agonist Injection Production Market Share 2023
Figure 29. China Based Manufacturers GLP-1 Agonist Injection Production Market Share 2023
Figure 30. Rest of World Based Manufacturers GLP-1 Agonist Injection Production Market Share 2023
Figure 31. World GLP-1 Agonist Injection Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 32. World GLP-1 Agonist Injection Production Value Market Share by Type in 2023
Figure 33. Short-acting Preparations
Figure 34. Long-acting Preparations
Figure 35. World GLP-1 Agonist Injection Production Market Share by Type (2019-2030)
Figure 36. World GLP-1 Agonist Injection Production Value Market Share by Type (2019-2030)
Figure 37. World GLP-1 Agonist Injection Average Price by Type (2019-2030) & (US$/Dose)
Figure 38. World GLP-1 Agonist Injection Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 39. World GLP-1 Agonist Injection Production Value Market Share by Application in 2023
Figure 40. Diabetes
Figure 41. Obesity
Figure 42. World GLP-1 Agonist Injection Production Market Share by Application (2019-2030)
Figure 43. World GLP-1 Agonist Injection Production Value Market Share by Application (2019-2030)
Figure 44. World GLP-1 Agonist Injection Average Price by Application (2019-2030) & (US$/Dose)
Figure 45. GLP-1 Agonist Injection Industry Chain
Figure 46. GLP-1 Agonist Injection Procurement Model
Figure 47. GLP-1 Agonist Injection Sales Model
Figure 48. GLP-1 Agonist Injection Sales Channels, Direct Sales, and Distribution
Figure 49. Methodology
Figure 50. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Novo Nordisk Eli Lilly AstraZeneca GSK Sanofi Amylin Huadong Medicine Shanghai Benemae Pharmaceutical Corporation
28 Mar 2024
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
